Intellia Therapeutics Inc (NTLA)

Investing Cash Flow

-$48.47M

TTM · Period ending: · USD

NTLA logo

NTLA Investing Cash Flow

Latest reported-$48.47M
NTLA TTM Cash from Investing (-$2.55M → -$48.47M)
High-resolution chart · PNG

NTLA investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Intellia Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-48,469,000
200,013,000
228,031,000
352,062,000
345,094,000
213,994,000
125,567,000
19,941,000
107,150,000
96,802,000
-31,347,000
-107,438,000
-139,295,000
-9,412,000
160,309,000
31,346,000
-415,678,000
-477,763,000
-550,778,000
-602,581,000
-357,180,000
-297,477,000
-214,487,000
24,315,000
146,643,000
76,929,000
25,176,000
-258,724,000
-229,088,000
-253,237,000
-260,782,000
-7,163,000
-7,407,000
-7,779,000
-10,091,000
-11,099,000
-9,444,000
-9,319,000
-6,165,000
-3,609,000
-3,606,000
-3,046,000
-2,554,000
-2,447,500
-1,845,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.